Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation